## **Core Concept**
Acetylation is a major metabolic pathway for certain drugs, where an acetyl group is introduced to the drug molecule, often changing its activity and solubility. This process involves the enzyme **N-acetyltransferase** (NAT) and is crucial for the metabolism of several drugs, including some antibiotics and antihypertensives. Acetylation status can categorize individuals as fast or slow acetylators, influencing drug plasma levels and efficacy.

## **Why the Correct Answer is Right**
Procainamide is primarily metabolized through **N-acetylation** to N-acetylprocainamide (NAPA), which has antiarrhythmic properties. Isoniazid, Hydralazine, and Sulfasalazine are also metabolized by acetylation. However, without specific details on options A, B, C, and D, we focus on the general principle that drugs not metabolized by acetylation would not be affected by the acetylator phenotype.

## **Why Each Wrong Option is Incorrect**
- **Option A:** If A is Isoniazid, it is incorrect because Isoniazid is indeed metabolized by acetylation.
- **Option B:** If B is Hydralazine, it is incorrect because Hydralazine is also metabolized by acetylation.
- **Option D:** If D is Sulfasalazine, it is incorrect because Sulfasalazine undergoes acetylation.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the rate of acetylation can significantly affect the plasma concentrations of drugs like Isoniazid and Hydralazine. **Slow acetylators** may achieve higher plasma concentrations and are at increased risk of toxicity, whereas **fast acetylators** may have lower plasma concentrations, potentially reducing efficacy.

## **Correct Answer:** .